PMI
Picard Medical, Inc.
AMEX: PMI · HEALTHCARE · MEDICAL DEVICES
$4.39
+0.00% today
Updated 2026-07-31
Market cap
$12.37M
P/E ratio
—
P/S ratio
2.26x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$0 – $14
Volume
46.4M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-8.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →203 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 85.50% QoQ
+ Debt/equity -2.26x — low leverage
Risks
- Altman Z -8.27 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-3.83M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.11M | $5.04M | $4.39M | $4.94M | $5.47M |
| Net income | $-11.17M | $-15.57M | $-21.05M | $-27.00M | $-7.62M |
| EPS | — | — | — | — | $-0.73 |
| Free cash flow | $-10.75M | $-10.64M | $-11.87M | $-15.67M | $-3.83M |
| Profit margin | -271.53% | -308.72% | -479.50% | -546.56% | — |
Peer comparison
Smart narrative
Picard Medical, Inc. trades at $4.39. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -8.27, it sits in the distress. TTM revenue stands at $5.47M.
Frequently asked questions
What is Picard Medical, Inc.'s stock price?
Picard Medical, Inc. (PMI) trades at $4.39, on a P/S of 2.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Picard Medical, Inc. overvalued?
Picard Medical, Inc. carries a Smart Value Score of 31/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is Picard Medical, Inc.'s revenue?
Picard Medical, Inc.'s trailing twelve-month revenue is $5.47M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Picard Medical, Inc.'s Altman Z-Score is -8.27, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeAMEX
CurrencyUSD
Quick metrics
P/S ratio2.26x
ROE—
Beta—
50D MA$0.18
200D MA$2.05
Shares out0.10B
Float0.04B
Short ratio—
Avg volume46.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—